Medication info
SimvaRoad Tablets 20 mg (Simvastatin)

SimvaRoad Tablets 20 mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Jongkundang Pharmaceutical Co., Ltd.
Appearance
Yellowish-brown, rectangular film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200200173 · Notified 2002.05.29 · Insurance code 643301480

Summary

Main use
Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. The recommended dose is 5 ~ 40 mg of this drug once daily in the evening. Adjust the dose as appropriate based on the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this drug, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this drug once daily in the evening. This drug should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not feasible. (2) In elderly patients, the maximum reduction in cholesterol levels can be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This drug is effective when used alone or in combination with a bile acid sequestrant. When this drug is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Drug under Precautions for Use) and fenofibrate), the dose of this drug must not exceed 10 mg daily. (6) Use in patients with renal impairment As this drug is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, treatment should be initiated at 5 mg daily and the patient should be monitored carefully.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or more between dose adjustments.

Ingredients

Manufacturer
Jongkundang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular disease

  • Coronary artery disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • non-fatal myocardial infarction
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. It lowers the risk of cardiac death and the incidence of myocardial infarction and stroke in adult patients with a history of vascular diseases such as coronary artery disease, diabetes, peripheral vascular disease, and stroke. Additionally, it reduces the risk of complications after vascular interventions. For patients with hyperlipidemia, it effectively reduces total cholesterol and LDL cholesterol while increasing HDL cholesterol, aiding in the treatment of dyslipidemia. Specifically, it is used as an adjunct to diet in pediatric patients with familial hypercholesterolemia to lower cholesterol levels. Therefore, this drug is very effective for the treatment of cardiovascular diseases and hyperlipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. The recommended dose is 5 ~ 40 mg of this drug once daily in the evening. Adjust the dose as appropriate based on the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this drug, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this drug once daily in the evening. This drug should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not feasible. (2) In elderly patients, the maximum reduction in cholesterol levels can be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this drug must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this drug must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This drug is effective when used alone or in combination with a bile acid sequestrant. When this drug is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Drug under Precautions for Use) and fenofibrate), the dose of this drug must not exceed 10 mg daily. (6) Use in patients with renal impairment As this drug is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, treatment should be initiated at 5 mg daily and the patient should be monitored carefully.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or more between dose adjustments.

Precautions

This medication can cause serious muscle-related side effects, such as myopathy and rhabdomyolysis. The risk is higher, especially with high doses, so caution is advised when taking 80 mg. This drug should not be used in patients who have allergies to this medication or its components, have liver disease or persistently elevated liver enzyme levels of unknown cause, are pregnant or breastfeeding, are taking strong CYP3A4 inhibitors, are taking certain medications (gemfibrozil, cyclosporine, danazol), or have lactose intolerance. Patients with poor liver function, alcohol dependence, renal impairment, hypothyroidism, hereditary muscle disorders, elderly patients, and women should use this medication with caution, and if muscle-related symptoms occur, they should consult a physician immediately. While taking this medication, it is important to closely monitor for symptoms such as muscle pain, tenderness, and weakness. If these symptoms occur, it is important to stop taking the drug immediately and inform healthcare professionals. Furthermore, this medication is metabolized in the liver, so regular liver function tests are necessary, and the drug should be discontinued if hepatitis or liver dysfunction symptoms occur. This medication may interact with various drugs, so patients taking other medications should inform their healthcare provider, especially when combining it with CYP3A4 inhibitors, certain lipid-lowering agents, calcium channel blockers, nicotinic acid, antibiotics, antifungals, etc. Women who are pregnant or may become pregnant should not use this medication, and if pregnancy occurs during treatment, it must be stopped immediately and a doctor should be consulted. It should also be avoided in breastfeeding women. Children and elderly patients require dose adjustments and caution, especially this medication is not for children under 10 years old. In case of an overdose, patients should immediately seek medical attention for appropriate treatment, and this medication should be kept out of the reach of children. Finally, it is advisable to avoid consuming certain foods like grapefruit juice while taking this medication, and always consult healthcare professionals about other medications being taken or health conditions.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 88 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • extraocular muscle dysfunction
  • facial partial paralysis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • severe muscle weakness
  • ocular muscle weakness
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • fatty liver changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • progression of cataracts
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • diabetes
  • sensory impairment in limbs
  • paresthesia
  • cold sensation
  • reduced muscle strength
  • thrombocytopenia
  • lupus-like erythema syndrome
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • interstitial lung disease
  • myoglobinuria
  • vomiting
  • mucus stool

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to store at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Yellowish-brown, rectangular film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.